Adjuvant Chemotherapy for Resected Non-small Cell Lung Cancer
暂无分享,去创建一个
[1] R. Livingston,et al. [A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIa non-small-cell lung cancer]. , 2001, Cancer Radiothérapie.
[2] Renato Martins,et al. Erlotinib in previously treated non-small-cell lung cancer. , 2005, The New England journal of medicine.
[3] R. Rosell,et al. ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation (OBS) in completely resected (stage I-III) non-small-cell lung cancer (NSCLC) patients (pts): Final results after 70-month median follow-up. On behalf of the Adjuvant Navelbine International Trialist Association , 2005 .
[4] H. Kato,et al. A randomized trial comparing adjuvant chemotherapy versus surgery alone for completely resected pN2 non-small cell lung cancer (JCOG9304). , 2004, Lung cancer.
[5] H. Wada,et al. Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] A randomized trial of postoperative adjuvant chemotherapy in non-small cell lung cancer (the second cooperative study). The Study Group of Adjuvant Chemotherapy for Lung Cancer (Chubu, Japan). , 1995, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[7] R. Arriagada,et al. Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma. A randomized trial of 267 patients , 1995 .
[8] Robert N. Hughes,et al. Cancer: Principles and Practice of Oncology , 2005 .
[9] L. Seymour,et al. O-58 Quality of life in a trial of adjuvant chemotherapy for early stage completely resected non-small cell lung cancer (NCIC CTG BR.10) , 2003 .
[10] G. Giaccone,et al. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer. , 2003, Journal of the National Cancer Institute.
[11] R. Gralla,et al. Does adjuvant chemotherapy improve survival in non small cell lung cancer (NSCLC)? A pooled-analysis of 6494 patients in 12 studies, examining survival and magnitude of benefit , 2005 .
[12] The benefit of adjuvant treatment for resected locally advanced non-small-cell lung cancer. The Lung Cancer Study Group. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] G. Luporini,et al. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. The Elderly Lung Cancer Vinorelbine Italian Study Group. , 1999, Journal of the National Cancer Institute.
[14] H. Wada,et al. Postoperative oral administration of UFT for completely resected pathologic stage I non-small cell lung cancer: the West Japan study group for lung cancer surgery (WJSG), the 4th study , 2001 .
[15] C. Mountain,et al. Revisions in the International System for Staging Lung Cancer. , 1997, Chest.
[16] S. Burdett,et al. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials , 1998, The Lancet.
[17] R. Gray,et al. Randomized phase II/III trial of paclitaxel (P) plus carboplatin (C) with or without bevacizumab (NSC #704865) in patients with advanced non-squamous non-small cell lung cancer (NSCLC): An Eastern Cooperative Oncology Group (ECOG) Trial - E4599 , 2005 .
[18] R. Schilsky,et al. Randomized Clinical Trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in Stage IB Non-Small Cell Lung Cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] H. Wada,et al. Postoperative adjuvant chemotherapy with PVM (Cisplatin + Vindesine + Mitomycin C) and UFT (Uracil + Tegaful) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial. West Japan Study Group for lung cancer surgery (WJSG). , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[20] C. Gridelli,et al. Chemotherapy for elderly patients with non-small cell lung cancer: a review of the evidence. , 2005, Chest.
[21] H. Wada,et al. Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] Mustafa. Abstract , 1952 .
[23] M. Gail,et al. Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] Bengt Bergman,et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. , 2004, The New England journal of medicine.
[25] C. Bokemeyer,et al. Adjuvant chemotherapy after complete resection of non-small cell lung cancer. , 2008, Deutsches Arzteblatt international.
[26] M. Handa,et al. A randomized trial of postoperative UFT therapy in p stage I, II non-small cell lung cancer: North-east Japan Study Group for Lung Cancer Surgery. , 2003, Lung cancer.
[27] Robert Livingston,et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. , 2005, The New England journal of medicine.
[28] K. Matsuo,et al. Role of Adjuvant Chemotherapy in Patients With Resected Non-Small-Cell Lung Cancer: Reappraisal With a Meta-analysis of Randomized Controlled Trials , 2006 .
[29] E. Holmes. Postoperative chemotherapy for non-small-cell lung cancer. , 1993, Chest.
[30] C. Gridelli,et al. Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials , 2005, BMC Cancer.
[31] D. Parkin,et al. Global cancer statistics in the year 2000. , 2001, The Lancet. Oncology.
[32] F. Shepherd,et al. Improving Survival and Reducing Toxicity with Chemotherapy in Advanced Non-Small Cell Lung Cancer , 2005, Treatments in respiratory medicine.
[33] T. Treasure,et al. Postoperative chemotherapy for non-small cell lung cancer: A systematic review and meta-analysis. , 2004, The Journal of thoracic and cardiovascular surgery.
[34] 富永 祐民,et al. A Randomized Controlled Trial of Postoperative Adjuvant Chemotherapy in Non-small Cell Lung Cancer , 1992 .
[35] R. Gray,et al. O-086a Randomized phase II/III trial of paclitaxel (P) plus carboplatin (C)with or without bevacizumab (NSC #704865) in patients with advanced non-squamous non-small cell lung cancer (NSCLC): An Eastern Cooperative Oncology Group (ECOG) Trial — E4599 , 2005 .
[36] Schell,et al. Adjuvant Chemotherapy for Resected Non-Small Cell Carcinoma of the Lung: Why We Still Don't Know. , 1998, The oncologist.
[37] Y. Shim,et al. Postoperative adjuvant chemotherapy for stage I non-small cell lung cancer. , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[38] R. Tsuchiya,et al. Adjuvant chemotherapy for completely resected stage III non-small-cell lung cancer. Results of a randomized prospective study. The Japan Clinical Oncology Group. , 1993, The Journal of thoracic and cardiovascular surgery.
[39] O. Brodin,et al. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials , 1995 .
[40] C. Gridelli,et al. Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[41] M. Parmar,et al. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[42] L. Rubinstein,et al. Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small-cell lung cancer. The Lung Cancer Study Group. , 1993, Journal of the National Cancer Institute.
[43] L. Rubinstein,et al. Combined modality treatment for resected advanced non-small cell lung cancer: local control and local recurrence. , 1988, International journal of radiation oncology, biology, physics.
[44] S. Pyrhönen,et al. Adjuvant chemotherapy after radical surgery for non-small-cell lung cancer: a randomized study. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[45] O. Doi,et al. Postoperative Adjuvant Chemotherapy in Non-small Cell Lung Cancer. Results of a Prospective Randomized Study. , 1992 .
[46] H. Kato,et al. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. , 2004, The New England journal of medicine.
[47] M. Imaizumi. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer. , 2005, Lung cancer.
[48] Y. Ichinose,et al. [Adjuvant chemotherapy for non-small cell lung cancer]. , 2006, Gan to kagaku ryoho. Cancer & chemotherapy.